Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Catherine Sarta"'
Autor:
Cory D. Fulcher, Carlos Thomas, Nicolas F. Schlecht, Michael B. Prystowsky, Bradley A. Schiff, Richard V. Smith, Andrea Lopez, Nicole Kawachi, Thomas J. Belbin, Gregory Rosenblatt, Evripidis Gavathiotis, Catherine Sarta, Geoffrey Childs, Chandan Guha, Thomas M. Harris, Denis E. Reyna, Thomas J. Ow, Pilib Ó Broin
Publikováno v:
Oncotarget
Mechanisms of treatment resistance in head and neck squamous cell carcinoma (HNSCC) are not well characterized. In this study, HNSCC tumors from a cohort of prospectively enrolled subjects on an ongoing tissue banking study were divided into those th
Autor:
Michael B. Prystowsky, Catherine Sarta, Nicolas F. Schlecht, Richard V. Smith, Ashish A. Ankola, Robert D. Burk
Publikováno v:
Oral Oncology. 49:911-917
Summary Objective To demonstrate the importance of comorbid conditions in head and neck squamous cell carcinoma (HNSCC), we assessed the association between comorbidity and survival in an inner-city population of HNSCC patients. Patients and methods
Autor:
Jonathan J. Beitler, Catherine Sarta, Madhur Garg, Richard V. Smith, Randall P. Owen, Ravindra Yaparpalvi
Publikováno v:
Head & Neck. 30:933-938
Background. Regional control for advanced nodal disease has been only marginally affected by concurrent che- moradiation, hyperfractionation, concomitant boost, or acceler- ated external radiation. Methods. Twenty-five necks in 24 patients received b
Autor:
Hillel W. Cohen, Andrew B. Tassler, Richard V. Smith, Thomas J. Ow, Nathan Gonik, Stefan Shuaib, Catherine Sarta, Bradley A. Schiff
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 154(1)
American Society of Anesthesiology guidelines recommend preoperative fasts of 6 hours after light snacks and 8 hours after large meals. These guidelines were designed for healthy patients undergoing elective procedures but are often applied to intuba
Autor:
Umekalsoom Malik, Lakshmi Rajdev, Abdissa Negassa, Jane M. Manalo, Catherine Sarta, Joseph A. Sparano, Joshua P. Raff, Yelena Novik, Una Hopkins
Publikováno v:
Clinical Breast Cancer. 4:420-427
This study was designed to determine the efficacy and toxicity of weekly docetaxel in metastatic breast cancer when given alone (for HER2/neu negative disease) or with trastuzumab (for HER2/neu overexpressing disease). Patients with metastatic breast
Publikováno v:
Medical Oncology. 20:53-58
Fludarabine is an active agent in low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Paclitaxel is also active in patients with refractory lymphoma, and preclinical data suggest an additive effect with fludarabine in vitro. We perform
Publikováno v:
Laryngoscope
Laryngoscope, Wiley, 2013, 123, pp.678-682
Laryngoscope, Wiley, 2013, 123, pp.678-682
Minimally invasive surgery has become the standard of care in many organ systems. Head and neck surgery has incorporated transoral surgery, either laser microsurgery or robotic resection, in the management of pharyngeal and laryngeal cancers. To date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c35e1c9d2bb590caa754087bf13e06
https://halshs.archives-ouvertes.fr/halshs-01457150
https://halshs.archives-ouvertes.fr/halshs-01457150
Autor:
Edward L. Schwartz, Catherine Sarta, Bernard A. Mason, David H. Henry, Peter H. Wiernik, Joseph A. Sparano, Janice P. Dutcher, Xiaoping Hu, Howard Ratech, Ruy Soeiro
Publikováno v:
Journal of Clinical Oncology. 14:3026-3035
PURPOSE To determine the following: (1) the feasibility of combining the antiretroviral didanosine (ddl) with a 96-hour continuous intravenous (IV) infusion of cyclophosphamide (800 mg/m2), doxorubicin (50 mg/m2), and etoposide (240 mg/m2) (CDE) plus
Autor:
Catherine Sarta, Paula Silverman, Joseph A. Sparano, Nicholas Robert, Ummekalsoom R. Malik, Usha Venkatraj, Hillard Lazarus
Publikováno v:
Journal of Clinical Oncology. 14:2576-2583
PURPOSE To determine the maximum-tolerated dose (MTD) of mitoxantrone that could be safely used in combination with cyclophosphamide and filgrastim in patients with advanced breast carcinoma. PATIENTS AND METHODS Twenty-seven patients with metastatic
Autor:
Anu G. Gaba, Thomas J. Belbin, Lucian R. Chirieac, Robert I. Haddad, Mimi Kim, Juan Lin, Missak Haigentz, Roger Keresztes, John M. Greally, Bruce Culliney, Catherine Sarta, John J. Wright, Geoffrey I. Shapiro, John M. Mariadason, Richard V. Smith
Publikováno v:
Oral oncology. 48(12)
Summary Objectives Patients with advanced squamous cell carcinoma of the head and neck (SCCHN) have limited treatment options. Inhibition of histone deacetylases (HDACs) represents a novel therapeutic approach warranting additional investigation in s